Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2008
10/30/2008CA2684638A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
10/30/2008CA2684615A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/30/2008CA2684562A1 New use for cannabinoid-containing plant extracts
10/30/2008CA2684552A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds
10/30/2008CA2684479A1 Pharmaceutical formulations containing lipoic acid derivatives
10/30/2008CA2684330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008CA2684240A1 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008CA2684084A1 Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
10/30/2008CA2684003A1 Novel compounds as cannabinoid receptor ligands
10/30/2008CA2683946A1 Triazole derivatives which are smo antagonists
10/30/2008CA2683517A1 Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
10/30/2008CA2682605A1 Single chain fc, methods of making and methods of treatment
10/30/2008CA2682390A1 Pdgfr.beta.-specific inhibitors
10/30/2008CA2682356A1 7-substituted indole mcl-1 inhibitors
10/30/2008CA2682354A1 7-nonsubstituted indole mcl-1 inhibitors
10/30/2008CA2680769A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985701A2 Genes differentially expressed in breast cancer
10/29/2008EP1985634A1 Modulators of p-selectin glycoprotein ligand 1
10/29/2008EP1985633A1 Kit of parts for the treatment of cancer or infectious diseases
10/29/2008EP1985309A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1985302A1 Medicament for treatment of tumor and the use thereof
10/29/2008EP1985293A1 Method for producing denatured substance of lactalbumin
10/29/2008EP1985285A2 Compositions and methods for treating lymphoma
10/29/2008EP1985283A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier
10/29/2008EP1984370A1 Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
10/29/2008EP1984353A1 Aurora kinase modulators and method of use
10/29/2008EP1984350A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
10/29/2008EP1984333A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
10/29/2008EP1984331A1 Pyrrolidine derivatives as erk inhibitors
10/29/2008EP1984329A2 Vitamin d analog - rak, methods and uses thereof
10/29/2008EP1984007A1 Use of local immune suppression to enhance oncolytic viral therapy
10/29/2008EP1984005A1 Use of gallium(iii) complexes for the treatment of melanomas
10/29/2008EP1983997A2 Crystalline forms of a farnesyl dibenzodiazepinone
10/29/2008EP1983990A1 A3 adenosine receptor allosteric modulators
10/29/2008EP1983984A2 Tuberous sclerosis treatment
10/29/2008EP1861100B1 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
10/29/2008EP1660504B1 Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents
10/29/2008EP1660474B1 Substituted thiophenes and uses thereof
10/29/2008EP1648889B1 Isethionate salt of a selective cdk4 inhibitor
10/29/2008EP1596857B1 Pmcol for the treatment of prostate cancer
10/29/2008EP1505959B1 Use of edg receptor binding agents in cancer
10/29/2008EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease
10/29/2008EP1406698B1 Lipoxin analogs as novel inhibitors of angiogenesis
10/29/2008EP1278868B9 Mutated form of arginine deiminase
10/29/2008EP1208217B1 Antibody dependent enhancement (ade) of alphavirus infection
10/29/2008EP1156823B1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/29/2008EP1137434B1 New cancer treatments
10/29/2008EP1076564B1 Compositions for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/29/2008EP1071460B1 INTERNALIZING ErbB2 ANTIBODIES
10/29/2008EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
10/29/2008EP0961831B1 Human endokine alpha
10/29/2008EP0898580B3 Methods and means for inhibition of cdk4 activity
10/29/2008EP0752872B1 Nadh oxidase as a target in diagnosis and therapy
10/29/2008CN101297038A Method for prediction of effectiveness of RAR-alpha agonist
10/29/2008CN101296944A Engineered anti-IL-23 antibodies
10/29/2008CN101296928A Compounds and compositions as protein kinase inhibitors
10/29/2008CN101296924A Pyrazole-isoquinoline urea derivatives as P38 kinase inhibitors
10/29/2008CN101296916A Dihydroxyanthraquinones and their use
10/29/2008CN101296909A Pyrazine derivatives and use as pI3K inhibitors
10/29/2008CN101296697A Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
10/29/2008CN101296695A Combinations comprising AMXAA for the treatment of cancer
10/29/2008CN101294187A Method for sustained-releasing polypeptide with biological activity and application thereof
10/29/2008CN101294173A Method for the manufacture of bengamide derivatives
10/29/2008CN101293933A Polyglycol modified chitosan oligosaccharide fatty acid grafting article, preparing method and application thereof
10/29/2008CN101293924A Monoclone antibody with combined function epiposition, specificity of osteopontin and in preparing antineoplastic diversion medicaments
10/29/2008CN101293908A Modified oligonucleotides for telomerase inhibition
10/29/2008CN101293904A New compound, preparation method and application thereof
10/29/2008CN101293894A 2-propylidene-19-nor-vitamin D compounds
10/29/2008CN101293889A Water-soluble arteannuin derivative and preparation method thereof
10/29/2008CN101293886A Preparing method and application of white banksia rose endogenetic epiphyte product of snail optical black shell bacterium ketone A
10/29/2008CN101293869A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561lck tyrosine kinases
10/29/2008CN101293102A Non-virogene carrier for complexation platinum series antineoplastic medicament and preparing method thereof
10/29/2008CN101293100A P16INK4a antibody for treating cervical carcinoma
10/29/2008CN101293097A Recombined staphylococcus aureus enterotoxin O oral preparation and application thereof
10/29/2008CN101293096A Recombined staphylococcus aureus enterotoxin N oral preparation and application thereof
10/29/2008CN101293095A Recombined staphylococcus aureus enterotoxin Q oral preparation and application thereof
10/29/2008CN101293094A Recombined staphylococcus aureus enterotoxin K oral preparation and application thereof
10/29/2008CN101293093A Recombined staphylococcus aureus enterotoxin M oral preparation and application thereof
10/29/2008CN101293092A Recombined staphylococcus aureus enterotoxin I oral preparation and application thereof
10/29/2008CN101293088A Medicament for treating rectum cancer and stomach cancer
10/29/2008CN101293086A Medicament for easing pain and eliminating tumour and preparation method thereof
10/29/2008CN101293060A Traditional Chinese medicine for treating cytology specification adenocarcinoma
10/29/2008CN101293000A Pharmic pellet for treating caner
10/29/2008CN101292992A Pharmaceutical composition for treating large intestinal cancer
10/29/2008CN101292980A Pharmaceutical combination containing rapamycin for treating large intestine cancer
10/29/2008CN101292974A Pharmaceutical use of diacetyl diphenyl sulphone heptane in preventing and controlling chronic marrow-derived leukocythemia
10/29/2008CN101292966A Solid dispersion of resveratrol and glycosides and preparation method thereof
10/29/2008CN101292963A Antineoplastic patches for external use of bullatacin
10/29/2008CN101292957A Liposome preparation of teniposide phospholipid complexes and prepraring method thereof
10/29/2008CN101292956A Sustained-release injection containing methotrexate and its synergistic agent
10/29/2008CN101292955A Sustained-release injection containing fluorouracil synergistic agent and preparation method thereof
10/29/2008CN101292954A Anti-cancer medicament sustained-release injection
10/29/2008CN101292951A Recombined human vascellum esoderma inhibin durative action preparation, preparation method and application thereof
10/29/2008CN101292733A Scentless healthy garlic powder (piece) nonhygroscopic agglomeration oxidation disintegration resistant preparation method
10/29/2008CN100429316C Recombination adenovirus and its application
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100429224C Antitumor activity of squash protein and use thereof
1 ... 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 ... 2211